Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.

@article{Nalesnik2002ClinicopathologicCO,
  title={Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.},
  author={Michael Andrew Nalesnik},
  journal={Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer},
  year={2002},
  volume={159},
  pages={9-18}
}
Post-transplant lymphoproliferative disorder (PTLD) is a syndrome of uncontrolled lymphoid growth in the immunosuppressed transplant patient. Known risk factors include Epstein-Barr virus (EBV) seronegativity at the time of transplant, pediatric age and allograft type. Newer studies suggest that constitutional factors such as cytokine gene polymorphisms may also predispose to PTLD. Although PTLD may occur at any time, the majority of cases arise within the first two post-transplant years… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

Rapid generation of Epstein-Barr virus-specific T cells for cellular therapy.

Qi Hao, Y Yang, +3 authors Zuo Luan
Transplantation proceedings • 2014
View 10 Excerpts
Highly Influenced

Post-transplant lymphoproliferative disorders are not associated with IgG4 sclerosing disease.

Transplant infectious disease : an official journal of the Transplantation Society • 2014
View 3 Excerpts

Similar Papers

Loading similar papers…